Expression of peptide and other markers in lung cancer cell lines.

Expression of peptide and other markers in lung cancer cell lines. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Expression of peptide and other markers in lung cancer cell lines. Abstract Text:

A F Gazdar,D N Carney,K L Becker,L J Deftos,V Liang,W Go,P J Marangos,T W Moody,A R Wolfsen,M H Zweig,

Expression of peptide and other markers in lung cancer cell lines. Publishing Authors By Initials

AF Gazdar,DN Carney,KL Becker,LJ Deftos,V Liang,W Go,PJ Marangos,TW Moody,AR Wolfsen,MH Zweig,

For similar biochemical phenomena, metabolism, and nutrition: metabolism: peptide biosynthesis research abstracts see: biochemical phenomena, metabolism, and nutrition: metabolism: peptide biosynthesis research

PUBMED ID PMID:

MEDLINE DATE:

Expression of peptide and other markers in lung cancer cell lines. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Recent results in cancer research. Fortschritte de

VOLUME: 99

Page Numbers: 167-74

Journal Abbreviation: Recent Results Cancer Res.

ISSN: 0080-0015

DAY: 13

MONTH: 02

YEAR: 1985

Expression of peptide and other markers in lung cancer cell lines. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 44671

Expression of peptide and other markers in lung cancer cell lines. Keywords Mesh Terms:

KEYWORDS: Peptide Biosynthesis

MESH TERMS: metabolism

Chemical & Substance for Abstract: Expression of peptide and other markers in lung cancer cell lines. Information

Substance Name: Hormones

Registry Number: 0

Grant and Affiliation Information for Expression of peptide and other markers in lung cancer cell lines.

AFFILIATION:

Country: GERMANY, WEST

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Recent Results Cancer Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Expression of peptide and other markers in lung cancer cell lines Related Publications

• ADULT ORTHODONTICS AND MOUTH RECONSTRUCTION.
• Action of dichlone on the human erythrocyte membrane.
• Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005).
• Expression of peptide and other markers in lung cancer cell lines.
• Mammography quality assurance.
• Psychoanalysis, psychotherapy, and health services.
• Relative mortality of chronically ill geriatric patients with organic brain damage, before and after relocation.
• Use of a buccal exostosis autograft for alveolar ridge augmentation: an aid to implant placement.